Davis WB, Pacht ER, Spatafera M, Martin II WJ. Enhanced cytotoxic potential of alveolar macrophages from cigarette smoker. J Lab Clin Med 111:293-8, 1988
Garcia JGN, Martin II WJ. Lower respiratory tract defense mechanisms in health and disease. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yuninger JW, eds. Allergy: Principles and Practice. 3rd ed: CV Mosby; 1988:2-13.
Martin II WJ. A health policy approach to cigarette smoking and tobacco related diseases. J Clin Out Management 3:44-5, 1996
Behnia M, Robertson KA, Martin II W. Lung infections: role of apoptosis in host defense and pathogenesis of disease. Chest 117(6):1771-7, 2000
Wisniowski PE, Spech RW, Wu M, Doyle NA, Pasula R, Martin II WJ. Vitronectin protects alveolar macrophages from silica toxicity. Am J Respir Crit Care Med 162(2 Pt 1):733-9, 2000
American Lung Association Asthma Clinical Research Centers [WJ Martin II PI, ACRC, Indiana University. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 345(21):1529-36, 2001
Rom WN, Pinkerton KE, Martin WJ, Forastiere F. Global warming: a challenge to all American Thoracic Society members. Am J Respir Crit Care Med 177(10):1053-1054, 2008.
|